Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FFFNK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,574
Award facts
- Contract value 100% obligated
- $18,574.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $18,574.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen auto-injectors on October 16, 2025, with an ultimate completion date of October 17, 2025. This is a non-set-aside, competitively awarded contract for pharmaceutical supply to support military healthcare needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor in the federal medical procurement system, with this delivery order issued as a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical.
This delivery order is part of AmerisourceBergen Drug Corp's SPE2DX Indefinite Delivery Contract valued at $999,999,999.00 and extending through December 2026, which functions as a comprehensive global pharmaceutical support vehicle for the Defense Logistics Agency's Medical Supply Chain. The parent IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. Dupixent (dupilumab) is a specialty biologic medication used in treating inflammatory conditions, and this procurement reflects the Defense Logistics Agency's broader strategy of utilizing prime vendor contracts to efficiently distribute specialized pharmaceutical commodities across military healthcare systems.
Quick answers
Who was awarded contract SPE2DB26FFFNK?
SPE2DB26FFFNK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 16, 2025.
How much is contract SPE2DB26FFFNK worth?
The government has obligated $18,574 on SPE2DB26FFFNK.
Is contract SPE2DB26FFFNK an order under another contract?
Yes. SPE2DB26FFFNK is a delivery order under SPE2DB24D3013, an indefinite delivery contract.
Was contract SPE2DB26FFFNK competed?
The extent of competition for SPE2DB26FFFNK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award